Completed OBSERVATIONAL NCT06292988

Predictive Factors for Medullary Thyroid Cancer Aggressiveness (MYELO)

Predective Factors for Tumor Aggressiveness in Medullary Thyroid Cancer

Sponsor: Aristotle University Of Thessaloniki

Updated 5 times since 2024 Last updated: Jan 2, 2025 Started: Mar 1, 2024 Primary completion: Apr 15, 2024 Completion: Apr 15, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06292988, this observational or N/A phase trial focuses on Medullary Thyroid Cancer and remains completed. Sponsored by Aristotle University Of Thessaloniki, it has been updated 5 times since 2024, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2025 — Present [monthly]

Completed
Feb 2025 — Sep 2025 [monthly]

Completed

Status: Not Yet Recruiting → Completed
Sep 2024 — Feb 2025 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Apr 2024 — Jul 2024 [monthly]

Not Yet Recruiting

First recorded

Mar 2024

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Aristotle University Of Thessaloniki

Data source: Aristotle University Of Thessaloniki

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Ankara, Turkey (Türkiye) , Athens, Greece , Bangkok, Thailand , Barcelona, Spain , Belgrade, Serbia , Bern, Switzerland , Bhubaneswar, India , Bratislava, Slovakia , Brest, France , Brussels, Belgium and 32 more locations